CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 134 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $383,000 | +78.1% | 195,480 | +366.1% | 0.02% | +72.7% |
| Q3 2019 | $215,000 | -64.5% | 41,939 | -50.3% | 0.01% | -67.6% |
| Q2 2019 | $605,000 | -17.9% | 84,439 | +52.1% | 0.03% | -22.7% |
| Q1 2019 | $737,000 | +667.7% | 55,516 | +354.5% | 0.04% | +633.3% |
| Q4 2018 | $96,000 | -84.5% | 12,216 | -78.1% | 0.01% | -78.6% |
| Q3 2018 | $618,000 | -17.4% | 55,815 | -3.2% | 0.03% | -6.7% |
| Q1 2018 | $748,000 | +434.3% | 57,631 | +278.4% | 0.03% | +400.0% |
| Q4 2017 | $140,000 | +44.3% | 15,231 | -57.8% | 0.01% | +100.0% |
| Q2 2015 | $97,000 | -6.7% | 36,069 | +138.4% | 0.00% | -25.0% |
| Q1 2015 | $104,000 | – | 15,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |